Pharmaceuticals Companies By Eps

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Earnings Per Share
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Earnings Per ShareEfficiencyMarket RiskExp Return
1JAGX Jaguar Animal Health
20.2
(0.23)
 8.14 
(1.84)
2LLY Eli Lilly and
11.72
 0.05 
 1.97 
 0.11 
3JAZZ Jazz Pharmaceuticals PLC
8.65
 0.14 
 1.55 
 0.22 
4MRK Merck Company
6.74
(0.05)
 1.72 
(0.08)
5NVS Novartis AG ADR
5.88
 0.21 
 1.34 
 0.28 
6JNJ Johnson Johnson
5.79
 0.19 
 1.13 
 0.22 
7ZTS Zoetis Inc
5.47
 0.00 
 1.64 
 0.01 
8PBH Prestige Brand Holdings
4.26
 0.06 
 2.38 
 0.14 
9OGN Organon Co
3.33
 0.05 
 2.75 
 0.14 
10NVO Novo Nordisk AS
3.32
(0.07)
 2.83 
(0.20)
11AMPH Amphastar P
3.06
(0.23)
 2.34 
(0.55)
12HRMY Harmony Biosciences Holdings
2.51
 0.01 
 3.03 
 0.02 
13SNY Sanofi ADR
2.4
 0.21 
 1.33 
 0.28 
14AZN AstraZeneca PLC ADR
2.25
 0.20 
 1.14 
 0.23 
15RPRX Royalty Pharma Plc
1.91
 0.28 
 1.85 
 0.51 
16COLL Collegium Pharmaceutical
1.86
 0.03 
 2.67 
 0.08 
17GSK GlaxoSmithKline PLC ADR
1.62
 0.16 
 1.73 
 0.27 
18PFE Pfizer Inc
1.41
 0.01 
 1.15 
 0.01 
19SUPN Supernus Pharmaceuticals
1.32
(0.05)
 2.70 
(0.13)
20CORT Corcept Therapeutics Incorporated
1.23
 0.08 
 3.59 
 0.30 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure. Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY